Skip to content
10-Q

Quarterly Report

LIGAND PHARMACEUTICALS INC LGND LGNDZ LGNXZ LGNYZ LGNZZ

0000886163-25-000063

← back to feed
Filed
Nov 7, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 4, 2025 19.68M sh
Shares Diluted Q3 2025 · Sep 30, 2025 20.63M sh
Shares Diluted Q3 2025 · Sep 30, 2025 20.17M sh
Shares Diluted Q3 2025 · Sep 30, 2024 18.42M sh
Shares Diluted Q3 2025 · Sep 30, 2024 18.57M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $15M
Stock Repurchased Q3 2025 · Sep 30, 2024 $0
Capex Q3 2025 · Sep 30, 2025 $443K
Capex Q3 2025 · Sep 30, 2024 $1.11M
Operating Cash Flow Q3 2025 · Sep 30, 2025 $3.44M
Operating Cash Flow Q3 2025 · Sep 30, 2024 $68.58M
Short Term Investments Q3 2025 · Sep 30, 2025 $525.15M
Short Term Investments Q3 2025 · Dec 31, 2024 $183.86M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $139.38M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $72.31M
Stockholders Equity Q3 2025 · Sep 30, 2025 $950.17M
Stockholders Equity Q3 2025 · Jun 30, 2025 $827.31M
Stockholders Equity Q3 2025 · Mar 31, 2025 $795.59M
Stockholders Equity Q3 2025 · Dec 31, 2024 $830.44M
Stockholders Equity Q3 2025 · Sep 30, 2024 $841.18M
Stockholders Equity Q3 2025 · Jun 30, 2024 $775.2M
Stockholders Equity Q3 2025 · Mar 31, 2024 $806.52M
Stockholders Equity Q3 2025 · Dec 31, 2023 $700.91M
Current Liabilities Q3 2025 · Sep 30, 2025 $30.54M
Current Liabilities Q3 2025 · Dec 31, 2024 $37.11M
Total Liabilities Q3 2025 · Sep 30, 2025 $526.6M
Total Liabilities Q3 2025 · Dec 31, 2024 $111.34M
Current Assets Q3 2025 · Sep 30, 2025 $753.92M
Current Assets Q3 2025 · Dec 31, 2024 $331.56M
Total Assets Q3 2025 · Sep 30, 2025 $1.48B
Total Assets Q3 2025 · Dec 31, 2024 $941.77M
Eps Diluted Q3 2025 · Sep 30, 2025 $5.68
Eps Diluted Q3 2025 · Sep 30, 2025 $3.95
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.39
Eps Diluted Q3 2025 · Sep 30, 2024 $1.46
Eps Basic Q3 2025 · Sep 30, 2025 $5.99
Eps Basic Q3 2025 · Sep 30, 2025 $4.11
Eps Basic Q3 2025 · Sep 30, 2024 −$0.39
Eps Basic Q3 2025 · Sep 30, 2024 $1.50
Sga Expense Q3 2025 · Sep 30, 2025 $28.45M
Sga Expense Q3 2025 · Sep 30, 2025 $67.42M
Sga Expense Q3 2025 · Sep 30, 2024 $24.48M
Sga Expense Q3 2025 · Sep 30, 2024 $53.05M
Rd Expense Q3 2025 · Sep 30, 2025 $21.02M
Rd Expense Q3 2025 · Sep 30, 2025 $77.67M
Rd Expense Q3 2025 · Sep 30, 2024 $5.68M
Rd Expense Q3 2025 · Sep 30, 2024 $17M
Net Income Q3 2025 · Sep 30, 2025 $117.27M
Net Income Q3 2025 · Sep 30, 2025 $79.67M
Net Income Q3 2025 · Sep 30, 2024 −$7.17M
Net Income Q3 2025 · Sep 30, 2024 $27.06M
Net Income Q3 2025 · Jun 30, 2024 −$51.91M
Net Income Q3 2025 · Mar 31, 2024 $86.14M
Operating Income Q3 2025 · Sep 30, 2025 $54.93M
Operating Income Q3 2025 · Sep 30, 2025 $27.16M
Operating Income Q3 2025 · Sep 30, 2024 $3.14M
Operating Income Q3 2025 · Sep 30, 2024 −$12.97M
Revenue Q3 2025 · Sep 30, 2025 $115.46M
Revenue Q3 2025 · Sep 30, 2025 $208.42M
Revenue Q3 2025 · Sep 30, 2024 $51.81M
Revenue Q3 2025 · Sep 30, 2024 $124.32M